Flagship Pioneering, LLC Long-Term Concentrated

CIK: 0001400240 · Show all filings

Period: Q3 2024 (← Previous) (Next →)

Filing Date: Nov 14, 2024

Total Value ($000): $591,878 (100.0% shares, 0.0% debt)

Holdings (6)

MRNA Moderna Inc 52.3%

Value ($000) $309,567 Shares 4,632,149 Est. Cost $16.43 Unrealized +458.7%

FHTX Foghorn Therapeutics Inc 19.9%

Value ($000) $117,996 Shares 12,674,120 Est. Cost $19.16 Unrealized -62.2%

SANA Sana Biotechnology Inc 17.6%

Value ($000) $104,008 Shares 25,001,856 Est. Cost $32.56 Unrealized -83.9%

— Omega Therapeutics Inc 6.0%

Value ($000) $35,655 Shares 29,225,579 Est. Cost $17.39 Unrealized —

— Seres Therapeutics Inc 3.7%

Value ($000) $21,871 Shares 23,117,045 Est. Cost $7.75 Unrealized —

SYRS Syros Pharmaceuticals Inc 0.5%

Value ($000) $2,782 Shares 1,293,849 Est. Cost $7.03 Unrealized -48.9%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
MRNA	Moderna Inc	4,632,149	$309,567	52.3%	$16.43	+458.7%	COM	60770K107
FHTX	Foghorn Therapeutics Inc	12,674,120	$117,996	19.9%	$19.16	-62.2%	COM	344174107
SANA	Sana Biotechnology Inc	25,001,856	$104,008	17.6%	$32.56	-83.9%	COM	799566104
—	Omega Therapeutics Inc	29,225,579	$35,655	6.0%	$17.39	—	COM	68217N105
—	Seres Therapeutics Inc	23,117,045	$21,871	3.7%	$7.75	—	COM	81750R102
SYRS	Syros Pharmaceuticals Inc	1,293,849	$2,782	0.5%	$7.03	-48.9%	COM	87184Q206